AI Article Synopsis
- The study looks at how emotions affect our thinking skills, especially in people with Parkinson's disease.
- Researchers tested 25 patients by showing them faces with different emotions and asked them to remember who the faces were, not focusing on the emotions.
- They found that medicine that helps dopamine in the brain improves memory for angry faces but makes it harder to remember sad faces, showing how emotions and thinking are connected.
Article Abstract
The influence of emotional context on cognitive operations is of fundamental importance for the evolution of higher cognitive functions and their disturbance in neuropsychiatric disorders. The dopamine pathways projecting to prefrontal cortex and the basal ganglia are assumed to play a major role in such emotion-cognition interactions. Here we provide evidence for such a role by studying working memory for emotional faces in patients with Parkinson's Disease. We studied 25 patients with Parkinson's disease during their on and off medication states. Faces with emotional expressions (happy, angry, sad, neutral or fearful) were shown and the participants had to remember and later recall the identity of the faces ignoring the expressions. We found that dopaminergic medication enhances working memory for angry faces and suppresses it for sad faces. The results elucidate neurochemical mechanisms for the saliency of threatening information and support cognitive explanations of the antidepressant effects of dopamine. They also suggest a role for dopamine in changing emotional-cognitive biases rather than as a generic cognitive enhancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mds.23420 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!